Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy

被引：0
|
作者：
Alison M. Pease
Luis A. Riba
Ryan A. Gruner
Nadine M. Tung
Ted A. James
机构：
[1] Harvard Medical School,Department of Surgery, Beth Israel Deaconess Medical Center
[2] Harvard Medical School,Department of Surgery/Linsey BreastCare Center, Beth Israel Deaconess Medical Center
[3] Harvard Medical School,Department of Medicine/Division of Hematology – Oncology, Beth Israel Deaconess Medical Center
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：366 / 371
页数：5
相关论文
共 50 条
  • [11] Evaluation of relation between Oncotype DX recurrence score and adjuvant chemotherapy administration
    Kazzaz, D. R.
    Chen, C.
    Shankleton, J.
    Forsyth, M. T.
    Ganesh, R.
    Sims, M.
    Patt, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [12] BreastPRS Prognostic Score Is Comparable to Oncotype DX Recurrence Score
    van Laar, R.
    D'Alfonso, T. M.
    Flinchum, R.
    Brown, N.
    Saint John, L.
    Shin, S. J.
    LABORATORY INVESTIGATION, 2013, 93 : 73A - 73A
  • [13] BreastPRS Prognostic Score Is Comparable to Oncotype DX Recurrence Score
    van Laar, R.
    D'Alfonso, T. M.
    Flinchum, R.
    Brown, N.
    Saint John, L.
    Shin, S. J.
    MODERN PATHOLOGY, 2013, 26 : 73A - 73A
  • [14] Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia
    Lindsay J. Collin
    Ming Yan
    Renjian Jiang
    Kevin C. Ward
    Brittany Crawford
    Mylin A. Torres
    Keerthi Gogineni
    Preeti D. Subhedar
    Samantha Puvanesarajah
    Mia M. Gaudet
    Lauren E. McCullough
    npj Breast Cancer, 5
  • [15] Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia
    Collin, Lindsay J.
    Yan, Ming
    Jiang, Renjian
    Ward, Kevin C.
    Crawford, Brittany
    Torres, Mylin A.
    Gogineni, Keerthi
    Subhedar, Preeti D.
    Puvanesarajah, Samantha
    Gaudet, Mia M.
    McCullough, Lauren E.
    NPJ BREAST CANCER, 2019, 5 (1)
  • [16] Histopathologic variables predict Oncotype DX™ Recurrence Score
    Flanagan, Melina B.
    Dabbs, David J.
    Brufsky, Adam M.
    Beriwal, Sushil
    Bhargava, Rohit
    MODERN PATHOLOGY, 2008, 21 (10) : 1255 - 1261
  • [17] Oncotype Dx recurrence score risk groups according to Ki67, a predictor to be considered
    Namuche, F.
    Ruiz, R.
    Morante, Z.
    Aguilar, A.
    Gomez, H.
    CANCER RESEARCH, 2019, 79 (04)
  • [18] Impact of Oncotype DX Recurrence Score on Adjuvant Chemotherapy Recommendations in Young Patients with Breast Cancer
    Dodman, Keisha G.
    Williams, Austin D.
    De La Cruz, Lucy M.
    Tchou, Julia C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : E6 - E6
  • [19] Ki67 as a Predictor of Oncotype DX Recurrence Score and Its Impact on Health Care Cost
    Bittenbinder, R.
    Gallaty, A. M.
    Williams, C.
    Ochoa, D.
    Korourian, S.
    Henry-Tillman, R.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S72 - S72
  • [20] Association of Insulin Resistance and Higher Oncotype DX™ Recurrence Score
    Gordon, Nicole T.
    Alberty-Oller, Jaime J.
    Fei, Kezhen
    Greco, Giampaolo
    Gallagher, Emily J.
    LeRoith, Derek
    Feldman, Sheldon M.
    Killilea, Bridgid
    Boolbol, Susan K.
    Choi, Lydia
    Friedman, Neil
    Pilewskie, Melissa
    Port, Elisa
    Tiersten, Amy
    Bickell, Nina A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 5941 - 5947
12345